Pharma Journalist - Page 800 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Veracyte undertook 100,000 Afirma genomic tests to thwart unwanted surgeries diagnosed for Thyroid Cancer

CASI Pharmaceuticals acquired 25 U.S FDA-approved ANDAs from Sandoz

Sacred Oak Medical Center revokes agreement with RedShift Healthcare Management

FDA grants tentative approval for Perrigo’s Onexton Gel

Novartis proclaimed FDA approval of NDA for Lutathera

Stryker’s WEAVE Trial testifies endovascular treatment for ICAD patients

Novartis ventures into Licensing agreement with Spark Therapeutics

TechCare signs distribution agreement with MWMedical BV for Novokid Lice treatment device

FDA grants 510 (k) Clearance to market TECHLAB’S CAMPYLOBACTER QUIK CHEK and CAMPYLOBACTER CHEK Tests

FDA assents to BioAtla’s IND for BA3011